Highlight
This prospective, multicenter randomized controlled trial assessed early Shenfu injection (SFI) administration in ICU patients with sepsis. Although SFI did not reduce vasopressor requirements, significant improvements were seen in 28-day mortality and sublingual microcirculation without notable adverse events.
